The Future1 Dec 2020 12:39
Not sure if this came up in the recent presentation , but it is a huge positive going forward post covid.
The company have already a further two potential products to add to the cd4 platform in the form of TB and Cryptococcosis which from my understanding will start to be developed once TT and covid production is underway. I am not sure how long the development stage is for these products, but it is further evidence that there is and will be a strong collection of products going forward.